Cullinan Oncology Net Income Applicable To Common Shares History
| CGEM Stock | USD 12.76 0.02 0.16% |
Net Income Applicable To Common Shares | First Reported 2015-09-30 | Previous Quarter -58 M | Current Value -32.2 M | Quarterly Volatility 43.9 M |
Macro event markers
Latest Cullinan Oncology's Net Income Applicable To Common Shares Growth Pattern
Cullinan Oncology LLC's reported Net Income Applicable To Common Shares across a 10-year window follows in the chart below. Year-to-year shifts within a slightly volatile series are common for this type of metric. A widening range in Cullinan Oncology's Net Income Applicable To Common Shares can signal increasing variability in the underlying drivers. Combining this trend with margin and cash flow data gives a fuller picture of Cullinan Oncology's financial health. Quarter-over-quarter noise in Cullinan Oncology's Net Income Applicable To Common Shares is smoothed by the longer-term trend direction.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
All content is derived from available financial data inputs.
Net Income Applicable To Common Shares |
| Timeline |
Net Income Applicable To Common Shares Trend Statistics
| Arithmetic Mean | 25,061,741 | |
| Geometric Mean | 7,196,580 | |
| Coefficient Of Variation | 261.33 | |
| Mean Deviation | 55,355,329 | |
| Median | -704,663 | |
| Standard Deviation | 65,495,047 | |
| Sample Variance | 4289.6T | |
| Range | 199.9M | |
| R-Value | 0.63 | |
| Mean Square Error | 2740.9T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | 8,212,841 | |
| Total Sum of Squares | 68633.6T |
Cullinan Oncology Net Income Applicable To Common Shares History
| 2026 | 134.3 M | ||
| 2025 | 127.9 M | ||
| 2022 | 111.2 M | ||
| 2021 | -65.6 M | ||
| 2020 | -51.8 M | ||
| 2019 | -20.7 M | ||
| 2017 | -14.2 M | ||
| 2016 | -316.7 K | ||
| 2015 | -109.5 K | ||
| 2014 | -130.5 K |
Related Accounts
| Last Reported | End Of Year Estimate | ||
| Net Income Applicable To Common Shares | 127.9 M | 134.3 M |
Methodology, Assumptions & Data Sources
The Net Income Applicable To Common Shares trend below shows where Cullinan Oncology stands now versus the past. Big swings can signal sensitivity to the broader economy.
This section for Cullinan Oncology LLC is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Sell-side coverage, where present, supplements the data shown. Values may update on different source schedules. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.